Program
Thursday, April 23, 2026, 08:00 AM – 5:00 PM
Regenerative Medicine
- Global State of Regenerative Medicine: Where We Are, and Where We Must Go
- Autologous and Allogenic Stem Cells
- Next-Level OA Care: Innovative Turnkey Orthobiologic Strategies
- MSCs for Hip osteonecrosis
- Orthobiologics in Spine and Joint Treatment Algorithm
- Disc Disruption Debate: Surgery vs. Orthobiologics
- Transformative Turnkey Solutions in Clinical Orthobiologics
- IPSCs at scale: Manufacturing Personalized Organs
- Disc Regeneration with Endoscopic Discectomy and Orthobiologics
- Peripheral Blood Derived VSEL
- Subchondral Orthobiologic Injections: Spine and Joints
- Peridural Bone Marrow Aspirate in the Treatment of Spinal Cord Injuries
- Clinical Advances on Culturing and Cryopreservation of MSC from Autologous Adipose Tissue
- Acellular therapies: credibility, scalability, and clinical validation
- Bridging the Gap Between Research Excellence and Clinical Implementation
- Global Standards, Policy gaps, and Ethical Frameworks
- Translating Novel Stem Cell Science into Real-world Therapies
- Global Landscape: The Rise of Cell Therapy Tourism
- The Next Decade in Regenerative Science: From Cells to Systems
Friday April 24, 2026, 08:00 AM – 5:00 PM
Precision Medicine
- Precision Medicine Globally: Current State and Future Directions
- Omics: Personalized care for clinical and cost effectiveness
- Top 5 Emerging technologies that will revolutionize healthcare
- Gene therapy at the point of care: Viral vs. Non-Viral Vectors
- Safety First: Managing Off-Target Effects in Gene Editing
- Bioprinting: Organs vs Patches
- Nanotechnology: Diagnostic and Therapeutic; Toxicity and Safety
- AI and Cybersecurity: The past, present and future
- AI and LLMs in Accelerating Gene Therapy and Emerging Technolgies
- VR/AR/MR: The Evolution and Future road
- Combined Biotech Solutions: AI, VR, Robotics and beyond
- Regenerative Immunotherapies: CAR-T and Beyond
- Precision Medicine: Defining the Responders & Non-Responders
Longevity Medicine
- Biostacking for Longevity
- Telomeres, Epigenetics, and Longevity
- Peptides, Hormones, and Next-Gen Health Optimization
- Therapeutic Plasma Exchange
- The Morality of Organ Genesis: Xenotransplantation
- Senolytics and Senomorphics: Clinical Data
- Financial Modeling for Success in Longevity Medicine
- The Ethics of Access: Preventing a Healthspan Divide
Saturday April 25, 2026, 08:00 AM – 5:00 PM
Industry Update
- Medtech: Current Landscape and Future Directions
- Current portfolio and Pipeline products
- Top 5 innovative ideas of last 5 years
- The Economics of Cures: Financing $1 Million Therapies
- Regulatory Quagmire: Expedited Approval vs. Patient Safety
- Building the Future: Founders in Regenerative Innovation
- Leading the Charge: CEOs Shaping Regenerative Health
- Science in Action: CSOs Driving Medical Breakthroughs
Venture Forum
- Breakthrough Emerging Technologies making news and Sweeping the Market
- Seed & Series A: Where the Smart Money is Moving in Deep Science
- Series B & C: Clinical Milestones that Drive Valuation
- Which technologies are seeing the highest Healthcare Investment and Why?
- What are Investors looking for in Regenerative, Precision and Longevity Medicine?
- IPO Readiness: Key Metrics for Regenerative, Precision and Longevity Medicine
- Start-up showcase/pitches
- Global Health Equity and Infrastructure Development
- Patient Advocacy and the Push for Expanded Access
